Biologics APIs

Oct 14, 2017
By Pharmaceutical Technology Editors
Samsung BioLogics’ second facility adds 152,000 L of mAb drug substance capacity.
Oct 13, 2017
By Pharmaceutical Technology Editors
The committee has voted unanimously to approve Spark Therapeutics’ gene therapy candidate, Luxturna (voretigene neparvovec), for treating a genetically inherited blindness.
Oct 12, 2017
By Pharmaceutical Technology Editors
The companies have entered into a strategic collaboration to establish a new cell therapy and regenerative medicine manufacturing platform, which includes a new manufacturing facility in Belgium.
Oct 11, 2017
By Pharmaceutical Technology Editors
Johnson & Johnson’s Janssen Sciences Ireland UC will invest more than EUR 300 million (US$355 million) to expand manufacturing capacity for biologic medicines at its Ireland facility.
Oct 11, 2017
By Pharmaceutical Technology Editors
BARDA has entered a $12-million contract with biopharmaceutical firm Achaogen for the late-stage development of an antibiotic against resistant bacteria, and as a potential treatment for biowarfare agents.
Oct 02, 2017
By Pharmaceutical Technology Editors
Sartorius begins building a new, EUR 30-million (US$35.2 million) Cell Culture Technology Center in Ulm, Germany.
Sep 26, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
ADC Bio announces plans to expand into clinical and commercial drug manufacturing for ADCs.
Sep 02, 2017
Pharmaceutical Technology
Modeling tools help process engineers optimize a biopharmaceutical facility’s capacity.
Sep 01, 2017
Pharmaceutical Technology
Innovative new technologies released over the past several months seek to enhance bio/pharmaceutical development and manufacturing. 
Jul 18, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
The addition of 20,000 sq. ft. of manufacturing and office space increases Avecia’s Milford, Ma, oligonucleotide capacity to 3.0 mol.
native1_300x100
lorem ipsum